<i>F2RL3</i>基因甲基化水平在血栓性疾病中的表达

刘芸; 李玉洁; 田丰; 李树中

doi:10.13201/j.issn.1004-2806-b.2019.12.007

F2RL3基因甲基化水平在血栓性疾病中的表达

- 1. 江苏大学附属昆山医院(江苏昆山, 215300);
- 2. 昆山市第三人民医院

详细信息

通讯作者: 田丰,E-mail:983357002@qq.com

中图分类号: R364.1

收稿日期: 2019-05-26

Reduced levels of F2RL3 methylation in whole blood in thrombotic diseases

- 1. Kunshan Hospital, Jiangsu University, Kunshan, 215300, China;
- 2. Third People's Hospital of Kunshan City

More Information

Corresponding author: TIAN Feng, E-mail: 983357002@qq.com

Received Date: 26 May 2019

摘要

摘要: 目的:探讨血栓形成性疾病患者F2R样凝血酶/胰蛋白酶受体3(F2RL3)基因甲基化水平,以评价F2RL3基因甲基化鉴别血栓性疾病的效能。方法:收集246例血栓性患者的EDTA-K₂抗凝全血标本,包括颈内静脉血栓(IJVT)37例、下腔静脉栓塞(IVCT)49例、下肢静脉栓塞(LEVT)32例、心肌梗死(MI)52例、脑梗死(CI)76例和健康对照组(Ctrl)76例,采用实时荧光定量PCR技术检测全血F2RL3基因启动子甲基化水平,并分析其与危险因素的相关性。结果:①246例血栓性疾病患者全血F2RL3基因甲基化水平为(0.49±0.11),低于Ctrl组(0.60±0.15),差异有统计学意义(P＜0.05)。②静脉血栓患者(VT组)全血F2RL3基因甲基化水平为(0.50±0.08),动脉血栓者(AT组)F2RL3基因甲基化水平为(0.49±0.12),均低于Ctrl组(P＜0.05)。③IVCT组患者(0.48±0.08)、LEVT组患者(0.49±0.11)和CI患者(0.48±0.09)F2RL3基因甲基化水平低于Ctrl组,差异有统计学意义(P＜0.05)。结论:全血F2RL3基因甲基化水平降低可辅助诊断血栓形成性疾病。
- 血栓形成性疾病 /
- F2RL3 /
- 甲基化
Abstract: Objective:To analyze the methylation level of F2RL3(coagulation factor II thrombin receptor-like 3)gene in patients with various thrombotic diseases.Method:EDTA-2K anticoagulated whole blood were collected of total of 246 patients with thrombotic disease,including 37 cases of internal jugular vein thrombosis(IJVT),49 cases of inferior vena cava thrombosis(IVCT),32 cases of lower extremity venous thrombosis(LEVT),52 cases of myocardial infarction(MI),and 76 cases of cerebral infarction(CI)and 76 healthy controls(Ctrl).Real-time fluorescent quantitative PCR(RT-PCR)was used to detect the whole blood F2RL3 gene promoter methylation level.Result:In 246 patients with thrombotic disease,the F2RL3gene methylation level was decreased in whole blood samples,and the methylation level of F2RL3gene in venous thrombosis and arterial thrombosis was decreased.Conclusion:The reduction of F2RL3methylation level in whole blood can assist in the diagnosis of thrombotic diseases.
- thrombotic disease /
- F2RL3 /
- methylation

HTML全文

参考文献(7)

[1]	Vorchheimer DA,Becker R,et al.Platelets in atherothrombosis[J].Mayo Clin Proc,2006,81:59-68.
[2]	Varga-Szabo D,Pleines I,Nieswandt B.Cell adhesion mechanisms in platelets[J].Arterioscler Thromb Vasc Biol,2008,28:403-412.
[3]	Kadan M,Do[AKgˇ]anci S,Yildirim V,et al.In vitro effect of sodium nitrite on platelet aggregation in human platelet rich plasma--preliminary report[J].Eur Rev Med Pharmacol Sci,2015,19:3935-3939.
[4]	Xiao CC,Ren A,Yang J,et al.Effects of pioglitazone and glipizide on platelet function in patients with type 2 diabetes[J].Eur Rev Med Pharmacol Sci,2015,19:963-970.
[5]	Jones CI,Barrett NE,Moraes LA,et al.Endogenous inhibitory mechanisms and the regulation of platelet function[J].Methods Mol Biol,2012,788:341-366.
[6]	Tsai PC,Glastonbury CA,Eliot MN,et.al,Smoking induces coordinated DNA methylation and gene expression changes in adipose tissue with consequences for metabolic health[J].Clin Epigenetics,2018,10:126.
[7]	Hirano K.Kanaide H.Role of protease-activated receptors in the vascular system[J].J Atheroscler Thromb,2003,10:211-225.